Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESMory: Oxytocin and Estradiol Interaction in Fear and Emotion
NCT04330677Phase 1Completed
- Sponsor
- University Hospital Bonn
- Start
- Sep 2016
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray and estradiol topical in anxiety disorder and post-traumatic stress disorder (PTSD), sponsored by University Hospital Bonn. Started Sep 2016; status: completed.
02
Drugs
oxytocin nasal sprayestradiol topical
03
Conditions
anxiety disorderpost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04330677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330677.